Exact Sciences Corp (EXAS) Posts Q4 Loss of 18c/Share, Wider than Expected

Exact Sciences Corp (NASDAQ: EXAS) reported Q4 EPS of ($0.18), $0.01 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $1.04 million versus the consensus estimate of $1.02 million.

For earnings history and earnings-related data on Exact Sciences Corp (EXAS) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• CoStar Group acquires Zonda for $800M, adding new home data
• S&P 500 may pull back before midterms, but Citi says buy the dip